UNSPSC 51152007: Doxacurium

This classification denotes a muscle relaxant, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M78TVM3G5Z. European Medicines Agency schedules Doxacurium chloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06380MIG. Doxacurium chloride generally arises in the molecular formula C56H78CL2N2O16.

The term DOXACURIUM CHLORIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 2, no. 3, 1988, list 28.) As of Q4 2014, DOXACURIUM remains the US FDA Preferred Term for this commodity. Doxacurium bears US NLM identifiers UMLS ID C0058716 and NCI Concept Code C81000. SMILES: C[N+]1(CCC2=CC(=C(C(=C2C1CC3=CC(=C(C(=C3)OC)OC)OC)OC)OC)OC)CCCOC(=O)CCC(=O)OCCC[N+]4(CCC5=CC(=C(C(=C5C4CC6=CC(=C(C(=C6)OC)OC)OC)OC)OC)OC)C.[CL-].[CL-].

UNSPSC 51152007 Doxacurium, a Commodity code, nominally covers a specific neuromuscular blocking agent used in anesthesia and critical care settings. Recent state and local procurement activity under this code, however, shows a material mismatch: the single recent opportunity posted involves naloxone (an opioid antagonist) and drug deactivation systems rather than doxacurium. Naloxone and drug deactivation procurement through state and local health and safety initiatives represents community health and overdose-response infrastructure, which falls outside the nominal pharmaceutical scope of doxacurium. The Seminole County, Florida solicitation (IFB60459723LAS) sought 1,900 units of naloxone and 800 drug deactivation systems annually through competitive bidding, with quarterly deliveries to a county health building and a two-year initial term plus one-year renewal option. Vendors were required to include all shipping and delivery costs, maintain workers' compensation and general liability insurance, and comply with E-Verify and drug-free workplace certification. The procurement included potential FEMA funding and federal compliance requirements.

Activity under this code is sparse and geographically limited. The single recent opportunity originated in Seminole County, Florida, with a response deadline of July 26, 2023. No additional state or local solicitations under UNSPSC 51152007 are present in the recent-opportunities block, and the one available record does not align with the code's stated pharmaceutical purpose. Buyers evaluating this code should treat it as showing little relevant recent state and local procurement activity; the mismatch between the code definition and the naloxone/drug-deactivation solicitation suggests either a data-tagging error in the source or a code that does not reflect actual purchasing patterns in state and local markets.